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Abstract: Aim: To assess the prevalence of coronary artery disease (CAD) in asymptomatic subjects using multidetector 
computed tomography (MDCT) and its relationships to demographic and clinical risk factors.  
Material and method: We enrolled consecutive asymptomatic volunteers with no evidence of ischemic heart disease that 
underwent MDCT for the early detection of CAD. All MDCT findings were correlated with demographic and risk factors. 
A total of 2820 coronary segments were analyzed in 188 asymptomatic subjects (150 males and 38 females), aged 54.4 ± 
7.4 years. 
Results:  A  total  of  128  (68%)  demonstrated  MDCT  findings  compatible  with  CAD;  of  these  111  (86.7%)  had  non-
significant (diameter stenosis < 50%) and 17 (13.3%) had significant CAD (diameter stenosis > 50%). Compared with 
older subjects (mean age 56±8 years), younger subjects had a lower prevalence of MDCT findings of CAD 55.5% vs. 
12.5%, respectively (P<0.001), regardless of risk factors. Males had more CAD (mostly non-significant) compared with 
females (109 [72.7%] vs. 19 [50.3%], respectively; P= 0.007). Subjects with > 2 risk factors had a higher prevalence of 
CAD in general and significant CAD in particular (P<0.001). 
Conclusion: CAD  in asymptomatic population seems  to be not  uncommon. Using MDCT a high prevalence of non-
significant and low prevalence of significant CAD was discovered in middle age asymptomatic population.  
Keywords: Coronary artery disease, risk factors, multidetector computed tomography.  
INTRODUCTION 
  Cardiovascular disease is  the leading cause of death in 
the Western population accounting for 38.5% of all deaths 
[1]. About 40%
 of those who experience an acute coronary 
syndrome (defined as unstable angina, ST-elevation myocar-
dial infarction or non-ST elevation myocardial infarction) in 
a given year
 will die from it. Of notable interest, 50%
 of men 
and  64%  of  women  who  died
  following  acute  coronary 
events had no previous
 symptoms of this disease [2]. In addi-
tion, the estimated cost for treating CHD in the U.S. (direct 
and  indirect)  in  2006  will  approach  $142.5
  billion
  [3].  
For these reasons, early diagnosis is urgently needed. Until 
recently, the diagnosis and evaluation of CAD was based on 
cardiac catheterization performed mostly on ischemic and/or 
symptomatic  patients,  both  of  which  are  populations  with 
advanced disease. In asymptomatic persons, the emphasis is 
on the assessment of
 long-term risk and primary prevention 
of future clinical disease. Commonly, the first presentation 
of coronary atherosclerosis is acute myocardial infarction or  
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sudden  coronary  death.  Detection  of  CAD  before  its  ‘full 
blown’ manifestation may have a beneficial impact on the 
natural course of the disease. Hence, clinical risk-factor as-
sessment and stress testing, although they are good prognos-
tic  indicators,  cannot  serve  as  definitive  diagnostic  tools. 
Although risk stratification based on the cardiovascular risk 
profile is important in identifying cohorts at risk for future 
cardiovascular events, these data seem to be limited for the 
diagnosis or exclusion of CAD. The recently developed car-
diac  CT  in  2006  (Electron  Beam  and  Multidetector  Com-
puted Tomography [EBCT and MDCT, respectively]), with 
its high spatial and temporal resolution, is the first accessible 
and non-invasive imaging technique to enable assessment of 
CAD in asymptomatic individuals [4-6]. The purpose of this 
study was to examine the prevalence of atherosclerotic CAD 
in  an  asymptomatic  population  undergoing  MDCT  and  its 
relationship to demographic and known risk factors. 
MATERIALS AND METHODS  
Study Population 
  A total of 188 consecutive volunteers, with or without 
risk  factors,  underwent  MDCT  coronary  angiography  
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for the early detection of CAD. The study population was 
comprised  of  self-referrals  or  referred  by  their  physician 
without subjective or objective evidence of ischemic heart 
disease.  Written  informed  consent  was  obtained  from  all 
subjects included in the study. 
  Exclusion criteria included a history of previous cardio-
vascular events (myocardial infarction, unstable angina that 
required  hospitalization,  coronary  artery  bypass  grafting, 
clear evidence of objective ischemia during exercise or im-
aging  testing,  invasive  coronary  angiography,  or  coronary 
CT with evidence of CAD), impaired renal function (creatin-
ine level > 1.5 mg%), severe lung disease, multiple ectopic 
beats,  atrial  fibrillation,  heart  rate  >75  beats/min  despite 
therapy,  and  a  history  of  allergic  reaction  to  iodine-
containing  contrast.  The  medical  history  included  cardiac 
risk factors, previous cardiac investigations and drug treat-
ment. Cardiac risk factors were assessed before the examina-
tion and included 1) Diabetes mellitus (defined as a fasting 
glucose level of > 126 mg/dl or the need for insulin or oral 
hypoglycemic agents) [8], 2) Hypertension (defined as blood 
pressure > 140/90  mm Hg or the use of  anti-hypertension 
medications) [9], 3) Hyperlipidemia (defined as total choles-
terol  level  >  200  mg/dl  or  treatment  with  lipid-lowering 
agents) [10], 4) Tobacco use (defined as current smoking), 5) 
Positive family history (defined as presence of CAD in a first 
degree relative younger than 55 years for males or less than 
65 years for females) [11], and 6) Obesity (defined as body 
mass  index  >  30  kg/m)  [12].  All  patients  gave  written  
informed  consent  to  the  study  protocol  after  receiving  
a  full  explanation  of  the  procedure.  Institutional  review 
board approval is not required for retrospective observational 
studies.  
MDCT Scan Protocol 
  MDCT was performed using two different MDCT scan-
ners: LightSpeed 16 Pro (112 subjects) and LightSpeed VCT 
(76 subjects) (GE Healthcare) according to the protocol de-
scribed  earlier  [13,  14].  An  appropriate  heart  rate  for  the 
MDCT examination (< 70 beats/min) was achieved by oral 
administration  of  a  beta-blocker  (Atenolol  50  to  100  mg, 
based on body mass and basal heart rate) two hours prior to 
the examination. With the first scanner, the following scan-
ning  parameters  were  applied:  detector  collimation,  16  × 
0.625 mm; 120 kVp; 400–500 mAs; pitch range, 0.2–0.29; 
gantry rotation time, 0.42 second; slice thickness, 0.6 mm. 
On the second scanner, images were obtained with detector 
collimation, 64 × 0.625 mm; 120 kVp; 400–500 mAs; pitch 
range,  0.2–0.29;  gantry  rotation  time,  0.35  second;  slice 
thickness, 0.6 mm. ECG modulation was used in all MDCT 
examinations (ECG pulsing). The subjects were imaged in 
the supine position.  The distance from the carina  to 1 cm 
below the diaphragmatic face of the heart was covered. A 
bolus of 70–90 mL of Iomeron 400 (iomeprol 400 mgI/mL, 
Bracco) was IV injected (4 mL/s) via an 18-gauge catheter 
placed in the antecubital vein followed by a bolus of 40 mL 
of saline. Scanning delay was determined according to the 
Smart Prepare Protocol (GE Healthcare) an automatic bolus 
test; the region of interest was placed on the ascending aorta. 
The  subjects  were  instructed  to  maintain  an  inspiratory 
breath-hold during which the CT data and ECG trace were 
acquired. 
Image Reconstruction 
  Image reconstruction was performed using the retrospec-
tive  electrocardiographic gating method. Datasets were ac-
quired at phases 45%, 75%, and 85% of the R-R cycle. Other 
window  positions  within  the  cardiac  cycle  were  recon-
structed when unsatisfactory results were achieved. The im-
age  data  sets  were  processed  on  a  separate  workstation 
(ADW  4.2  and  4.6,  General  Electric  Medical  systems,  
Milwaukee,  WI)  and  analyzed  using  Curved  Multi-Planar 
Reconstruction (MPR) in multiple planes in addition to the 
axial  source  images.  Coronary  arteries  were  consensually 
reviewed by two experienced radiologists and a level 2 certi-
fied cardiologist. 
DATA ANALYSIS 
  CAD was defined as coronary wall atheromatous plaques 
which could be clearly distinguished from the vessel lumen, 
with or without luminal reduction, as previously described 
[15]. Atherosclerotic changes in each coronary segment were 
classified  as  1)  calcified  (plaques  with  high  density  com-
pared  to  the  contrast-enhanced  vessel  lumen)  2)  non-
calcified (soft) plaques with lower density, or 3) mixed (cal-
cified and non-calcified morphologies). Luminal narrowing 
was assessed as non-significant (diameter stenosis < 50%), 
and  significant  (defined  as  >  50%  diameter  stenosis).  For 
each participant, the number of diseased coronary segments, 
number of segments with obstructive lesions, and the num-
ber of each type of plaque was calculated. Subjects without 
coronary artery plaques were considered normal.  
STATISTICAL ANALYSIS 
  All analyses were performed using SPSS 11.5 software. 
The statistical analyses examined relationships between the 
different variables (demographic characteristics, risk factors, 
and MDCT findings) to the presence of significant and non-
significant CAD. Continuous variables were presented as the 
mean +  standard deviation. The x²-test was used for cate-
gorical variables. Student's t -test was used to compare nor-
mally distributed groups. The Spearman correlation was used 
to check for correlations between the ordinal variables and 
the existence of the disease. The relationship between multi-
ple risk factors and the presence of CAD was assessed with 
stepwise logistic regression. A two-tailed P value of < 0.05 
was considered significant.  
RESULTS 
  The study population included 150 (79.8%) males and 38 
females with a mean age of 54.4 ± 7.4 years. Twenty seven 
(14.5%) subjects had no risk factors, 63 (33.5%) had 1 risk 
factor, and 98 (52%) had ≥2 risk factors for CAD (Table 1). 
In this population, a positive family history of CAD, hyper-
lipidemia, and tobacco use were common (44.6%, 43.6% and 
36.7%,  respectively).  Less  common  were  hypertension 
(31%) and diabetes mellitus (12.7%). The cardiac CT was 
completed with no reported complications. A total of 2820 
coronary segments were analyzed of which 79 (2.8%) were 
not evaluated due to motion artifacts. The total number of 
coronary segments with findings of atherosclerotic plaques 
was 454 (16%); had soft, calcified, and mixed morphology 
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Table 1.  Baseline Characteristics of the Asymptomatic Study 
Population 
Variables  Asymptomatic Subjects n=188 (%) 
Age (years)¹  54.4±7.4 
Male  150 (79.8) 
Tobacco use  69 (36.7) 
Hyperlipidemia  82 (43.6) 
Hypertension  58 (30.85) 
Diabetes mellitus  24 (12.7) 
Family history of CAD  84 (44.6) 
No risk factors for CAD  27 (14.5) 
One risk factor for CAD  63 (33.5) 
> 2 risk factors for CAD  98 (52) 
¹Values are mean + SD, CAD; coronary artery disease. 
The majority of the study population were middle aged males with >2 risk factors for 
CAD. Common risk factors were positive family history of CAD, hyperlipidemia, and 
tobacco use. 
 
Table 2.  Multidetector  Computed  Tomography  Coronary 
Angiography Findings 
MDCT Findings  Number (%) 
Total evaluated segments  2820 
Non-evaluated segments  79 (2.8) 
Total segments with CAD  454 (16) 
Segments with soft plaques  123 (27.1) 
Segments with calcified plaques  147 (32.4) 
Segments with mixed plaques  184 (40.5) 
Subjects with CAD  128 (68)* 
MDCT;  multidetector  computed  tomography;  *percent  of  the  total  number  of  the  
study cohort (n=188). Using MDCT, a high prevalence of CAD was detected in our 
asymptomatic  population.  The  majority  of  atherosclerotic  plaques  were  mixed  and 
calcified.  
MDCT  findings  compatible  with  CAD.  Of  these,  111 
(86.7%) had non significant and 17 (13.3%) had significant 
CAD (Fig. 1). Of the 17 patients with significant CAD, 16 
(94.1%) had calcified and mixed morphology plaques. Sub-
jects  in  different  age  groups  (40-49,  50-59,  60-69,  70-79 
years) with ≥2 risk factors had a higher prevalence of CAD 
in general compared with those with only 1 risk factor (from 
70% to 100%, P<0.001) (Table 3 and Fig. 2), and significant 
CAD  in  particular  (P=0.029)  (Table  3  and  Fig.  3).  When 
different  age  groups  were  compared,  regardless  of  risk  
factors, older persons (mean age 56±8 years) had a higher 
prevalence of CAD of any degree compared with younger 
persons (mean age 52±6 years) (P=0.007) (Table 4), with the 
exception of those aged 70-79 years with one risk factor who 
had a prevalence of only 11.1%. After adjustment for other 
risk factors, males had more CAD (mostly non-significant) 
compared with females (109 [72.7%] vs. 19 [50.3%], respec-
tively; P= 0.007) (Table 4). When we evaluated specific car-
diac risk factors, MDCT findings of CAD were observed in 
about 70%-92% if one of the risk factors was hyperlipidemia 
(83%), hypertension (74%), family history of CAD (75%), 
diabetes mellitus (92%), or tobacco use (67%) (Table 4 and 
Fig.  4).  The  presence  of  CAD  of  any  degree  was  signifi-
cantly related to diabetes mellitus (P=0.007) and hyperlipi-
demia (P<0.001). Significant CAD was significantly related 
only to a history of diabetes mellitus (P<0.001) and hyper-
tension (P=0.042) (Table 4). On multivariate logistic regres-
sion analysis, significant independent predictors of any de-
gree of coronary atherosclerotic disease were male sex (OR 
1.46, P=0.001), older age (mean age≥ 56±8 years) (OR 1.09, 
P=0.002),  and  number  of  risk  factors  (>2)  (OR  1.84, 
P<0.001). After adjustment for age and gender, the presence 
of  >2  risk  factors  was  still  significantly  related  to  the  
presence of significant CAD.  
DISCUSSION  
  MDCT  angiography  is  a  highly  accurate,  non-invasive 
imaging technique with excellent negative predictive value 
that  approaches  100%  which  allows  CAD  to  be  ruled  out 
[16, 17]. Hoffmann et al. established the high accuracy of 
16-slice  MDCT  to  detect  significant  obstruction  (>50% 
stenosis)  with  segment-based  sensitivity,  specificity,  and 
positive  and  negative  predictive  values  of  95%,  98%,  
87%, and 99%, respectively, compared with catheter-based  
 
 
 
 
 
 
 
Fig. (1). Severity of coronary artery disease as detected by multidetector computed tomography coronary angiography. A high prevalence of 
non-significant and low prevalence of significant CAD was observed in our study cohort. 
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selective coronary angiography [18]. The early discovery of 
CAD in the asymptomatic population by this modality may  
encourage and motivate these patients to be more compliant 
and  to  begin  or  continue  to  make  life  style  changes.  In  
recent study, multislice coronary CT provided independent  
prognostic information over base-line clinical risk factors in 
patients with known and suspected CAD [19-22].  
  The aim of our study was to discover subclinical CAD in 
a cohort of asymptomatic individuals using MDCT, and to 
correlate  the  findings  with  demographic  characteristics  
and  risk  factors.  Of  interest,  coronary  atherosclerosis  was 
observed in the majority of our study population (68%), and 
most  (87%)  had  non-significant  CAD;  this  finding  might 
explain  why  they  were  asymptomatic.  Another  possible  
explanation is that the majority of subjects with significant 
CAD  had  calcified  and  mixed  morphology  plaques  which 
may  attribute  to  the  stability  and  lower  vulnerability  for  
active  coronary  disease  and  appearance  of  symptoms.  
Coronary occlusion and myocardial infarction may, in fact, 
Table 3.  Relationship  between  the  Number  of  Risk  Factors  for  Coronary  Artery  Disease  and  Multidetector  Computed  
Tomography Findings 
No. of Risk Factors   Normal Coronary Arteries n=60 (%)   Non-significant CAD n=111 (%)   Significant CAD  n=17 (%) 
0  15 (55.5)  12 (44.5)  0 (0) 
1  27 (42.8)  30 (47.6)  6 (9.5) 
> 2  18 (18.4)  69 (62.2)  11 (64) 
Subjects with >2 risk factors had more CAD of any degree than those with fewer risk factors. Even subjects with 0-1 risk factors had relatively a high prevalence of non- significant 
CAD. Significant CAD was observed only in subjects with risk factors, and mostly those with >2 risk factors. 
 
 
 
 
 
 
 
 
Fig. (2). Prevalence of CAD as it related to the number of risk factors. The presence of >2 risk factors was significantly related to high  
prevalence of CAD (P-value demonstrate the difference between 0 or 1 and > 2 risk factor). Of note, even subjects with no risk factors had 
relatively a high proportion of CAD. 
 
 
 
 
 
 
 
 
Fig. (3). Prevalence of significant CAD as it related to the number of risk factors. A low prevalence of significant CAD was discovered in an 
asymptomatic middle aged population. However, the presence of >2 compared to 0 or 1 risk factors was significantly related to a higher 
prevalence of significant CAD (P-value demonstrate the difference between 0 or 1 and > 2 risk factor).  
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arise  most  frequently  from  mild  to  moderate  stenosis  
[22-24].  These  angiographic  studies  showed  that  68%  of  
myocardial infarctions were attributable to so-called "angi-
ographically  silent"  lesions  (luminal  narrowing  <50%), 
whereas  only  14%  could  be  assigned  to  a  severe  stenosis 
(>70%)  [25].  A  recent  study  showed  that  non-obstructive 
CAD was indeed an independent predictor of future cardiac 
events [19]. Thus, our finding of a high prevalence of non-
significant CAD must be seriously considered.  
  Our  investigation  revealed  an  excellent  correlation  
between the prevalence of CAD and male sex, older age, and 
number (>2) of risk factors. Although unexpected, this corre-
lation was certainly not observed in age groups older than 70 
years. This finding could be explained by the small number 
[9] of participants in this subgroup. Males had 4-fold more 
CAD  than  females  of  the  same  age  and  number  of  risk  
factors. This finding might be because women in  this age 
group (mean 54 + 7 years) had a lower probability of the 
disease  compared with  men. Nearly one  sixth of coronary 
events in men occur before the age of 55 years. In women 
who had at  least  three risk factors,  absolute coronary risk 
exceeded 10% only after the age of 55 years [26]. In about 
13% of our study population, MDCT demonstrated obstruc-
tive coronary atherosclerosis related to older age and a his-
tory of two or more risk factors (i.e. diabetes mellitus and 
hypertension) which mandates further cardiovascular work-
up  (exercise  test,  isotope  scan  or  coronary  angiography). 
Diabetes  mellitus  presented  in  only  12.7%  of  our  study  
cohort and was significantly associated with any degree of 
CAD. Our analysis showed that patients with diabetes had 7-
fold more CAD than non-diabetics. This finding supports a 
previous study that showed a high rate of silent ischemia in a 
retrospective  analysis  of  1899  asymptomatic  patients  with 
type 2 diabetes, aged ≤60 years [27]. Patients with hyperten-
Table 4.  Comparison of Demographic and Risk Factors for Coronary Artery Disease by Multidetector Computed Tomography 
Findings 
Variables  Normal Coronary Arteries n=60  Non-significant CAD n=111  Significant CAD n=17  P value 
Age (years)*  52.2+6.3  54.9+7.8  58.1+6.3  0.007 
Male, n (%)  41 (27.3)  94 (62.7)  15 (10)  0.007 
Female, n (%)  19 (50)  17 (44.7)  2 (5.3)  0.85 
Hyperlipidemia, n (%)   14 (17)  59 (72)  9 (11)  < 0.001 
Hypertension, n (%)  15 (25.8)  34 (58.6)  9 (15.5)  0.020 
Family history of CAD  n (%)  21 (25)  57 (67.8)  6 (7.1%)  0.068 
Diabetes mellitus, n (%)  2 (8.3)  14 (58.3)  8 (33.3)  0.007 
Tobacco use, n (%)  23 (33.3)  42 (60.7)  4 (5.8)  0.78 
* Values are mean+SD.  
MDCT finding of CAD were observed in about 70-92% of those with the following risk factors: hyperlipdemia (83%), hypertension (74%), family history of CAD (75%), diabetes 
mellitus (92%), and tobacco use (67%). The presence of CAD of any degree was significantly related to older age (mean > 52+6 years), male sex, diabetes mellitus, and hyperlipi-
demia. Non-significant CAD was significantly related only with diabetes mellitus and a family history of CAD. Significant CAD was significantly related only to a history of diabe-
tes mellitus and hypertension. 
 
 
 
 
 
 
 
 
 
Fig. (4). Prevalence of CAD of any degree as it related to specific risk factors. HL- hyperlipidemia, HT- hypertension, FH- family history  
of CAD, DM- diabetes mellitus. CAD was observed in 67-92% of individuals with the risk factors hypertension, family history of CAD, 
hyperlipidemia, diabetes mellitus, or tobacco use. 
0
10
20
30
40
50
60
70
80
90
100
 
Prevalence 
of CAD (%) 
 
 
 
 
HL Smoking HT FH DM
Risk factor12    The Open Cardiovascular Medicine Journal, 2010, Volume 4  Zaid et al. 
sion had more significant CAD than normotensive patients. 
Family history and hyperlipidemia were the dominant risk 
factors,  and  were  significantly  associated  only  with  non-
significant CAD; this might be the main reason for the high 
prevalence  of  non-significant  CAD  in  our  study  cohort. 
Other traditional risk factors such as tobacco use were, un-
expectedly, not significantly related to any degree of CAD. It 
could be that, as a single risk factor, tobacco use does not 
sufficiently  affect  the  disease  unless  it  is  combined  with 
other CAD risk factors. Our results correlate well with those 
of the Framingham Study which  indicated that  the risk of 
CAD increases stepwise with the extent of risk-factor clus-
tering [28]. However, data from another studies showed that 
the presence of risk factors for CAD does not always indi-
cate the presence of the disease [29-31]. Previous study of 
MDCT in
 asymptomatic persons [32] suggested that testing 
could have both
 desirable effects (changes in behavior) and 
undesirable  ones
  (worry  and  increased  stress).  However,  a 
clinical trial in which
 coronary CT was used during screen-
ing  examinations  of  military
  personnel  found  that  positive 
results  alone  were  not  a  potent  motivational  force  for 
changes in behavior to reduce coronary risk
 factors [33]. The 
primary purpose of screening would be to identify patients 
whose prognosis could be improved with medical therapy or 
myocardial  revascularization.  No  randomized  controlled 
studies were found that assessed the value of CT screening in 
reducing cardiac events. A consensus statement on coronary 
CT was issued by American College of Cardiology and the 
American Heart Association (ACC/AHA) [34]. According to 
this consensus, coronary CT may be used in “selected” pa-
tients with  intermediate risk  according to  the Framingham 
Risk Score [35]. The  Blue  Cross, Blue Shield Association 
Technology Evaluation Center (medical policy on coronary 
CT) did not recommend the use of coronary CT for screen-
ing [36]. None of these guidelines recommend noninvasive 
testing  in an unselected
 asymptomatic population. In addi-
tion,  the  authors  of
  all  these  guidelines  expressed  concern 
that the results of noninvasive
 tests could lead to inappropri-
ate  or  unnecessary  diagnostic
  testing  and  interventions,  
including  coronary  angiography  and
  revascularization,  in 
asymptomatic persons.
 Hs-CRP is good marker for special 
group such as high risk and as prognostic marker after car-
diac events. It has low sensitivity and specificity for the ex-
tent of CAD. For high-risk and low-risk patients, additional 
noninvasive testing will generally not modify decisions re-
garding preventive interventions. However, for intermediate-
risk patients, those with an absolute 10-year risk of coronary 
events of approximately 10 to 20 percent according to the 
Framingham Risk Score [35], noninvasive testing with coro-
nary CT, exercise testing, or perhaps other tests, could im-
prove the assessment of risk and are probably cost-effective. 
Based on our results and those of other studies, considering 
the risk of excessive radiation [37] and contrast media, we 
suggest that coronary CT cannot be used to screen for CAD 
in the low risk, asymptomatic population.  
STUDY LIMITATIONS  
  Our study lacked outcome measures and did not establish 
cost-effective  parameters  to  support  or  refute  the  use  of 
MDCT in asymptomatic patients. It also lacked a systematic 
evaluation of our finding with other imaging modalities for 
physiological  assessments  or  invasive  strategies  for  lesion 
confirmation. We did not include the calcium score in the 
analysis. Our investigation was based on the rationale that 
calcium  scoring  sometimes  cannot  assess  the  severity  of 
atherosclerosis because soft  and mixed plaques, which are 
not detected by calcium score, might cause significant steno-
sis of the  coronary arteries.  The 2007 ACCF/AHA Expert 
Consensus  Document  on  coronary  artery  calcium  scoring 
concluded that because of its high false positive rate when 
applied to low risk populations, it cannot be recommended  
as  a  screening  tool  for  the  diagnosis  of  obstructive  CHD  
because of its low specificity [38].  
  Assessment of the coronary artery lumen on CT is diffi-
cult  when  severely  calcified  lesions  are  present.  The  poor 
differentiation between contrast-enhanced vessel lumen and 
high-density calcified plaques may lead to misinterpretation 
of stenotic lesions and may make some vascular segments 
unassessable. It is a concern that asymptomatic patient with 
calcified  atherosclerotic  changes  would  be  referred  for  
further testing (i.e. stress test) or even undergo coronary in-
tervention, which may be unnecessary. 
  Patient exposure to ionizing radiation represents, in fact, 
a major and still debated issue of coronary CT. In patients 
undergoing  coronary  CT  dose  reducing  strategies  such  
as  ECG  modulation  should  be  used  when  possible  and  
optimized  in  accordance  with  the  as  low  as  reasonably 
achievable principle [39]. 
CONCLUSION 
  CAD  in  asymptomatic  population  seems  to  be  not  un-
common. Using MDCT a high prevalence of non-significant 
and low prevalence of significant  CAD was discovered  in 
middle age asymptomatic population. Further investigations 
are  needed  to  confirm  the  clinical  implications  of  our  
findings.  
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